Loading...
The aryl hydrocarbon receptor ligand omeprazole inhibits breast cancer cell invasion and metastasis
BACKGROUND: Patients with ER-negative breast tumors are among the most difficult to treat and exhibit low survival rates due, in part, to metastasis from the breast to various distal sites. Aryl hydrocarbon receptor (AHR) ligands show promise as antimetastatic drugs for estrogen receptor (ER)-negati...
Saved in:
Published in: | BMC Cancer |
---|---|
Main Authors: | , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
BioMed Central
2014
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4226953/ https://ncbi.nlm.nih.gov/pubmed/25011475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-498 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|